RTX:NYSERTX Corporation Analysis

RTX is trading at $174.85, well above the DCF‑derived fair value of $75.75 and a trailing P/E of 32.8 that exceeds the industry average of 29.5, suggesting the stock is currently overvalued. The price sits just below the 20‑day SMA (175.43) and markedly under the 50‑day SMA (188.74), while the RSI of 40.6 indicates neutral momentum and the MACD histogram (+0.65) points to a modest bullish signal. Volatility remains elevated at 25.6% over the past 30 days, but the beta of 0.49 signals low systematic risk, and trading volume is stable. A dividend of $0.73 per share (1.58% yield) with a 51% payout ratio and recent board approval of a 7.4% increase underscores a sustainable income stream.
Fundamentally, RTX posted 8.7% revenue growth, solid operating margins (13.2%) and robust free cash flow of $7.23 B, supporting its dividend and ongoing investments such as the $26.5 M Collins Aerospace expansion in Florida. Analysts consensus remains a “Buy” with a mean target of $215, reflecting confidence in defense spending and aerospace demand, though the company's debt‑to‑equity of 57.2% and a forward P/E of 23.1 temper enthusiasm. The blend of stable defense contracts, dividend growth, and strategic capital deployment positions RTX for medium‑ to long‑term upside despite short‑term pricing pressure.